drugset / Trial / NCT00352066

Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together

NCT00352066

Phase 1 Completed 18 enrolled Avexa
Non-randomizedSingle-groupOpen-label

Summary

The aim of the study is to see if apricitabine or tipranavir affect the levels of each other in the blood (pharmacokinetic interaction) when they are dosed together.

Timeline

Start
2006-07
Primary completion
2006-08
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject apricitabine Small molecule